☆ 4.7 Letter

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

LEUKEMIA (2017)

Get Full Text
Add to Collection

Journal

LEUKEMIA
Volume 31, Issue 11, Pages 2523-2525

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2017.242

Keywords

-

Categories

Oncology Hematology

Funding

  1. Novartis Oncology
  2. Alfred und Angelika-GutermuthStiftung
  3. Verein Knochenmarktransplantation/Gentherapie Frankfurt (KGF)
  4. LOEWE Zentrum fur Zell-und Gentherapie

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.